.png)
Click on a session title below to see full description and presentation schedule.
Chair: Rajanikanth Madabushi, PhD – US Food and Drug Administration
Chair: Venkatesh Pilla Reddy, PhD – AstraZeneca
Speaker: Megan Gibbs, BSc, PharmD, PhD – AstraZeneca
Speaker: Niresh Hariparsad, PhD – AstraZeneca
Speaker: Akihiro Ishiguro, PhD – Pharmaceuticals and Medical Devices Agency
Speaker: Nina Isoherranen, MSc, PhD – University of Washington
Speaker: So Miyoshi, PhD – Pfizer R&D Japan
Speaker: Sheila Annie Peters, PhD – Boehringer-Ingelheim
Speaker: Kellie Schoolar Reynolds, PharmD – US Food and Drug Administration
Speaker: Andrew Rowland, BSc, PhD – Flinders University
Speaker: Vikram Sinha, PhD – Takeda
Speaker: Manthena Varma – Pfizer
Speaker: Carolien Versantvoort, PhD – Medicines Evaluation Board
Speaker: Xinning Yang, PhD – US Food and Drug Administration
Speaker: Ping Zhao, PhD – Bill & Melinda Gates Foundation
Pharmacometrics & Pharmacokinetics (PMK)
Membrane Transporter (MT)
Oncology (ONC)
Special Populations (SPO)
Early Development & Drug Safety (EDDS)
Global Health (GH)
Regulatory Science (RS)
Student & Trainee (ST)
Life Cycle Management (LCM)
Chair: Rajanikanth Madabushi, PhD – US Food and Drug Administration
@@@ Venkatesh Pilla Reddy, PhD – AstraZeneca ### 1184566###Chair###Director, Clinical Pharmacology and Pharmacometrics###AstraZeneca###Chair: Venkatesh Pilla Reddy, PhD – AstraZeneca
@@@ Megan Gibbs, BSc, PharmD, PhD – AstraZeneca ### 1487008###Speaker###VP, Global Head, Clinical & Quantitative Pharmacology###AstraZeneca###Speaker: Megan Gibbs, BSc, PharmD, PhD – AstraZeneca
@@@ Niresh Hariparsad, PhD – AstraZeneca ### 1487004###Speaker###Senior Director###AstraZeneca###Speaker: Niresh Hariparsad, PhD – AstraZeneca
@@@ Akihiro Ishiguro, PhD – Pharmaceuticals and Medical Devices Agency ### 1486999###Speaker###Division Director###Pharmaceuticals and Medical Devices Agency###Speaker: Akihiro Ishiguro, PhD – Pharmaceuticals and Medical Devices Agency
@@@ Nina Isoherranen, MSc, PhD – University of Washington ### 1487003###Speaker###Professor and Chair, Milo Gibaldi Chair###University of Washington###Speaker: Nina Isoherranen, MSc, PhD – University of Washington
@@@ So Miyoshi, PhD – Pfizer R&D Japan ### 1487001###Speaker###Head of Clinical Pharmacology###Pfizer R&D Japan###Speaker: So Miyoshi, PhD – Pfizer R&D Japan
@@@ Sheila Annie Peters, PhD – Boehringer-Ingelheim ### 1487000###Speaker###Early Asset Lead###Boehringer-Ingelheim###Speaker: Sheila Annie Peters, PhD – Boehringer-Ingelheim
@@@ Kellie Schoolar Reynolds, PharmD – US Food and Drug Administration ### 1070916###Speaker###Director, Division of Infectious Disease Pharmacology###US Food and Drug Administration###Speaker: Kellie Schoolar Reynolds, PharmD – US Food and Drug Administration
@@@ Andrew Rowland, BSc, PhD – Flinders University ### 1487005###Speaker###Associate Professor and Beat Cancer Mid-Career Research Fellow###Flinders University###Speaker: Andrew Rowland, BSc, PhD – Flinders University
@@@ Vikram Sinha, PhD – Takeda ### 1486998###Speaker###Vice President, Global Head Quantitative Clinical Pharmacology###Takeda###Speaker: Vikram Sinha, PhD – Takeda
@@@ Manthena Varma – Pfizer ### 1487007###Speaker######Pfizer###Speaker: Manthena Varma – Pfizer
@@@ Carolien Versantvoort, PhD – Medicines Evaluation Board ### 1206945###Speaker###senior clinical pharmacology assessor###Medicines Evaluation Board###Speaker: Carolien Versantvoort, PhD – Medicines Evaluation Board
@@@ Xinning Yang, PhD – US Food and Drug Administration ### 1143613###Speaker###Policy Lead###US Food and Drug Administration###Speaker: Xinning Yang, PhD – US Food and Drug Administration
@@@ Ping Zhao, PhD – Bill & Melinda Gates Foundation ### 1429091###Speaker###Senior Program Officer###Bill & Melinda Gates Foundation###Speaker: Ping Zhao, PhD – Bill & Melinda Gates Foundation
.png)